These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37318233)

  • 1. Author Reply to Letter to the Editor: In Response to: Comment on Sutton et al.'s "Allopurinol and the Risk of Diabetic Macular Edema among U.S. Veterans with Type 2 Diabetes".
    Sutton SS; Magagnoli J; Cummings TH; Hardin JW; Ambati J
    Ocul Immunol Inflamm; 2024 Sep; 32(7):1454-1456. PubMed ID: 37318233
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on Sutton et al.'s "Allopurinol and the Risk of Diabetic Macular Edema Among U.S. Veterans with Type 2 Diabetes".
    Lai SW
    Ocul Immunol Inflamm; 2024 Sep; 32(7):1509. PubMed ID: 37145497
    [No Abstract]   [Full Text] [Related]  

  • 3. Allopurinol and the Risk of Diabetic Macular Edema among U.S. Veterans with Type 2 Diabetes.
    Sutton SS; Magagnoli J; Cummings TH; Hardin JW; Ambati J
    Ocul Immunol Inflamm; 2024 Aug; 32(6):969-975. PubMed ID: 36749950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical and other treatments of diabetic macular edema: an update.
    Christoforidis JB; D'Amico DJ
    Int Ophthalmol Clin; 2004; 44(1):139-60. PubMed ID: 14704528
    [No Abstract]   [Full Text] [Related]  

  • 5. Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab.
    Sfikakis PP; Markomichelakis N; Theodossiadis GP; Grigoropoulos V; Katsilambros N; Theodossiadis PG
    Diabetes Care; 2005 Feb; 28(2):445-7. PubMed ID: 15677814
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to the comment by Ilhan et al. on our paper entitled 'effect of macular ischemia on intravitreal ranibizumab treatment for diabetic macular edema'.
    Chatziralli I; Douvali M; Theodossiadis P; Rouvas AA
    Ophthalmologica; 2015; 233(2):116. PubMed ID: 25547525
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein BE; Myers CE; Howard KP; Klein R
    JAMA Ophthalmol; 2015 May; 133(5):503-10. PubMed ID: 25502808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.
    Sahu AK; Majji AB
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6890; author reply 6890-1. PubMed ID: 21123772
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
    Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of the Diabetic Retinopathy and Genetic Factors Significance in the Development of Diabetic Retinopathy in Patients with Diabetes Mellitus type I and II in Slovakia (DIARET SK study). Overview of Actual Findings and Design of the Epidemiological DIARET SK Study].
    Krásnik V; Štefaničková J; Fabková J; Bucková D; Helbich M
    Cesk Slov Oftalmol; 2015 Sep; 71(5):237-42. PubMed ID: 26782726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nonsteroidal anti-inflammatory drugs in diabetic retinopathy.
    Malukiewicz G; Stafiej J; Lesiewska H; Sikorski B
    Klin Oczna; 2016 Aug; 118(1):44-47. PubMed ID: 29715408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
    Eleftheriadou A; Riley D; Zhao SS; Austin P; Hernández G; Lip GYH; Jackson TL; Wilding JPH; Alam U
    Diabetologia; 2024 Jul; 67(7):1271-1282. PubMed ID: 38584180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macular edema: Real life safety and efficacy].
    Majstruk L; Qu-Knafo L; Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2020 Mar; 43(3):197-204. PubMed ID: 32000989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database.
    Hammes HP; Welp R; Kempe HP; Wagner C; Siegel E; Holl RW;
    PLoS One; 2015; 10(7):e0132492. PubMed ID: 26177037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor: Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial.
    Călugăru D; Călugăru M
    Ophthalmic Surg Lasers Imaging Retina; 2018 Mar; 49(3):160. PubMed ID: 29554381
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy.
    Chung YR; Park SW; Choi SY; Kim SW; Moon KY; Kim JH; Lee K
    Cardiovasc Diabetol; 2017 Jan; 16(1):4. PubMed ID: 28061854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of qiming granule for diabetic macular edema: A protocol for systematic review and meta-analysis.
    Hu Z; Yang M; Xie C; Gao H; Fu X; Xie H; Liu Y
    Medicine (Baltimore); 2019 Oct; 98(42):e17496. PubMed ID: 31626104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial, Ethnic, and Gender Disparities in Diabetic Macular Edema Clinical Trials.
    Bowe T; Salabati M; Soares RR; Huang C; Singh RP; Khan MA; Williams BK; Sridhar J; Chiang A; Cohen MN; Klufas MA; Gupta OP; Yonekawa Y; Xu D; Kuriyan AE
    Ophthalmol Retina; 2022 Jun; 6(6):531-533. PubMed ID: 35131526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-therapeutic Biomarkers for Ranibizumab Therapy among Type 2 Diabetic Patients with Diabetic Macular Edema.
    Paine SK; Bhattacharjee CK; Bhaduri G; Pramanik S; Borah PK; Mahanta J; Basu A; Mondal LK
    Optom Vis Sci; 2021 Jan; 98(1):81-87. PubMed ID: 33394935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial resolution of diabetic macular oedema after systemic treatment with furosemide.
    Ciardella AP
    Br J Ophthalmol; 2004 Sep; 88(9):1224-5. PubMed ID: 15317721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.